Healthcare - Medical - Devices - NASDAQ - US
$ 4.22
2.93 %
$ 54.3 M
Market Cap
-6.49
P/E
CASH FLOW STATEMENT
-3.84 M
OPERATING CASH FLOW
4.45 M
INVESTING CASH FLOW
-200 K
FINANCING CASH FLOW
FREE CASH FLOW ANALYSIS
Free Cash Flow Analysis
Nexalin Technology, Inc.
| Net Income | -4.65 M |
| Depreciation & Amortization | 4.25 K |
| Capital Expenditures | -109 K |
| Stock-Based Compensation | 2.41 M |
| Change in Working Capital | -769 K |
| Others | -1.09 M |
| Free Cash Flow | -3.94 M |
Cash Flow
Millions
| Dec-2023 | Dec-2022 | Dec-2021 | Dec-2020 | Dec-2019 | |
|---|---|---|---|---|---|
| OPERATING CASH FLOW | |||||
| Net Income | (4.6) | (1.7) | (6.1) | (3.4) | (5.0) |
| Depreciation & Amortization | 4.25 K | 535 | 537 | 429 | 535 |
| Deferred Income Tax | 0 | 0 | (4.1) | 66.4 K | (0.3) |
| Stock Based Compensation | 2.4 | 0.3 | 4.5 | 2.0 | 0.6 |
| Other Operating Activities | (0.8) | (0.2) | 4.1 | 8.82 K | 3.8 |
| Change in Working Capital | (0.8) | (0.6) | 0.5 | 0.5 | 0.3 |
| Cash From Operations | (3.8) | (2.2) | (1.1) | (0.9) | (0.7) |
| INVESTING CASH FLOW | |||||
| Capital Expenditures | (0.1) | 0 | 0 | 648 | 0 |
| Other Items | 4.6 | (6.8) | 0 | 0 | 0 |
| Cash From Investing Activities | 4.5 | (6.8) | 0 | 648 | 0 |
| FINANCING CASH FLOW | |||||
| Common Stock Repurchased | 0 | 0 | 0 | 0 | 0 |
| Total Debt Repaid | 0 | 37.2 K | 0.2 | 18.3 K | 23.5 K |
| Dividends Paid | 0 | 0 | 0 | 0 | 0 |
| Other Financing Activities | (0.2) | 3.47 K | 1.5 | 0.9 | 0.7 |
| Cash From Financing Activities | (0.2) | 8.5 | 1.7 | 0.9 | 0.7 |
| CHANGE IN CASH | |||||
| Net Change In Cash | 0.4 | (0.5) | 0.6 | 15 K | 47.7 K |
| FREE CASH FLOW | |||||
| Free Cash Flow | (3.9) | (2.2) | (1.1) | (0.9) | (0.7) |